NEXVET BIOPHARMA PUB LTD CO's ticker is NVET and the CUSIP is G6503X109. A total of 13 filers reported holding NEXVET BIOPHARMA PUB LTD CO in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,000 | -44.4% | 800 | -66.5% | 0.00% | – |
| Q1 2017 | $9,000 | -74.3% | 2,390 | -74.5% | 0.00% | – |
| Q4 2016 | $35,000 | -14.6% | 9,390 | -5.6% | 0.00% | – |
| Q3 2016 | $41,000 | -26.8% | 9,950 | -18.0% | 0.00% | – |
| Q2 2016 | $56,000 | +12.0% | 12,140 | -20.3% | 0.00% | – |
| Q1 2016 | $50,000 | -2.0% | 15,240 | +2.6% | 0.00% | – |
| Q4 2015 | $51,000 | -80.0% | 14,850 | -78.8% | 0.00% | – |
| Q3 2015 | $255,000 | -8.3% | 70,079 | +25.5% | 0.00% | – |
| Q2 2015 | $278,000 | +17.3% | 55,851 | +89.2% | 0.00% | – |
| Q1 2015 | $237,000 | – | 29,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 877,134 | $3,412,000 | 1.46% |
| Broadfin Capital, LLC | 1,127,200 | $4,385,000 | 0.53% |
| Boxer Capital, LLC | 154,840 | $602,000 | 0.13% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,648,696 | $10,303,000 | 0.11% |
| Latimer Light Capital, L.P. | 104,948 | $408,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 795,000 | $3,093,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 44,400 | $173,000 | 0.00% |
| NORGES BANK | 34,313 | $133,000 | 0.00% |
| Advisor Group, Inc. | 90 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,390 | $9,000 | 0.00% |